Mirabegron API Manufacturers & Suppliers

Looking for Mirabegron API 223673-61-8?

Description:

Here you will find a list of producers, manufacturers and distributors of Mirabegron. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

Mirabegron 

Synonyms:

Myrbetriq  

Cas Number:

223673-61-8 

DrugBank number:

DB08893 

Unique Ingredient Identifier:

MVR3JL3B2V

Mirabegron is a type of Urological agents

Urological agents are a vital subcategory of pharmaceutical active pharmaceutical ingredients (APIs) used for the treatment of various urological disorders. These agents encompass a wide range of drugs that target the urinary system, including the kidneys, bladder, ureters, and urethra.

One common type of urological agent is the alpha-blockers. These medications work by relaxing the smooth muscles in the prostate gland, bladder neck, and urethra, thereby improving urine flow and relieving symptoms associated with benign prostatic hyperplasia (BPH). Alpha-blockers are frequently prescribed to alleviate urinary retention and reduce the urgency and frequency of urination.

Another important class of urological agents is the antimuscarinics. These drugs act by blocking the action of acetylcholine, a neurotransmitter responsible for the contraction of the bladder muscle. By inhibiting these contractions, antimuscarinics help to reduce overactive bladder symptoms, such as frequent urination, urgency, and urge incontinence.

Additionally, urological agents may include medications for the treatment of urinary tract infections (UTIs), such as antibiotics targeting specific bacteria commonly responsible for UTIs. These antibiotics work by inhibiting bacterial growth and eradicating the infection.

The development of urological agents plays a crucial role in improving the quality of life for patients suffering from urological conditions. These pharmaceutical APIs offer effective therapeutic options to manage symptoms and address the underlying causes of urological disorders. By targeting specific mechanisms within the urinary system, urological agents offer precise and targeted treatment approaches. It is essential for healthcare professionals to stay updated on the latest advancements in urological agents to ensure optimal patient care.

Mirabegron (Urological agents), classified under Genitourinary Agents

Genitourinary agents are a category of pharmaceutical active ingredients (APIs) that are specifically designed to target and treat disorders related to the genitourinary system. The genitourinary system encompasses the organs and structures involved in the production, storage, and elimination of urine, as well as the reproductive organs.

These APIs play a crucial role in the treatment of various genitourinary conditions, including urinary tract infections (UTIs), erectile dysfunction, urinary incontinence, benign prostatic hyperplasia (BPH), and other related disorders. They exert their therapeutic effects by interacting with specific receptors or enzymes in the genitourinary system, regulating physiological processes, and restoring normal function.

Some commonly used genitourinary agents include alpha-blockers, which relax the smooth muscles in the prostate and bladder neck, improving urine flow in patients with BPH. Additionally, phosphodiesterase type 5 inhibitors (PDE5 inhibitors) are widely prescribed for erectile dysfunction, as they enhance blood flow to the penile tissues, facilitating erection.

These APIs are typically formulated into various dosage forms, such as tablets, capsules, creams, gels, or injections, allowing for convenient administration to patients. The development and production of genitourinary agents involve stringent quality control measures and compliance with regulatory guidelines to ensure safety, efficacy, and consistent product performance.

In summary, genitourinary agents form a crucial category of pharmaceutical APIs used to treat a range of disorders affecting the genitourinary system. Their targeted mechanisms of action and diverse dosage forms make them valuable tools in improving genitourinary health and enhancing patients' quality of life.

• Minakem from France, product country of origin Canada
• Jubilant Pharmova from India, product country of origin India
• SETV Global from India, product country of origin India
• Saneca Pharma from Slovakia, product country of origin Slovakia
• Apino Pharma Co., Ltd. from China, product country of origin China
• Global Pharma Tek from India, product country of origin India
• Zhejiang Hengkang Pharmaceutical Co. Ltd from China, product country of origin China
• AXXO GmbH from Germany, product country of origin World
• Shandong Octagon Chemicals Limited from China, product country of origin China
• Hangzhou Verychem Sci&Tec Co.Ltd from China, product country of origin China
• Dr. Reddy's from India, product country of origin India
• Infar, S.A. from Spain, product country of origin Spain
• Zhejiang Hongyuan from China, product country of origin China
• Vasudha Pharma Chem Ltd. from India, product country of origin India
• Cosma from Italy, product country of origin Italy
• MSN Labs. from India, product country of origin India
• Lupin from India, product country of origin India
• ZCL Chemicals from India, product country of origin India
• Hetero Drugs from India, product country of origin India
• Micro Labs from India, product country of origin India
• Piramal Pharma Solutions from India, product country of origin India

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.